FF 2022 www.dirittofederale.admin.ch La versione elettronica firmata è quella determinante
Notifiche e domande d'autorizzazione per attività in sistemi chiusi con organismi geneticamente modificati o patogeni Notifiche e domande d'autorizzazione pervenute dal 1° settembre 2021 al 31 dezembre 2021 Numero
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A000223-02 20.12.2021
ZH
Riccarda Capaul Universität Zürich, Institut für Medizinische Virologie Winterthurerstrasse 190 8057 Zürich
Diagnostik von humanpathogenen Viren, Viruskrankheiten und ausgewählten Mikroorganismen
A000310-02 15.12.2021
BS, BL
Nickel Beatrice Swiss Tropical and Public Health Institute Socinstrasse 4002 Basel
Diagnostik von Tropenerkrankungen
A010091-01 23.09.2021
SH
Stephanie Karmann Merck & Cie Schaffhausen | Qualitätskontrolle | Bio Analytik Im Laternenacker 8200 Schaffhausen
Mikrobiologisches Qualitätskontroll-Labor für pharmazeutische Wirkstoffproduktion (API)
A010161-05 13.10.2021
VD
Werner Held Characterization of T cell University of Lausanne | responses to infection and Department of Fundamental cancer Oncology | Ludwig Center for Cancer Research Ch. des Boveresses 1066 Epalinges
A050616-03 04.11.2021
VD
Anne-Laure Mahul-Mellier Role of protein aggregaEPFL - SV Faculté des tion in neurodegenerative sciences de la vie Station 19 disease 1015 Lausanne
A050654-02 03.11.2021
BS
Urs Jenal Universität Basel, Biozentrum / Pharmazentrum Spitalstrasse 41 4056 Basel
2022-0203
Data d'arrivo
Regulation von Biofilmbildung und Persistenz in Pseudomonas aeruginosa
FF 2022 180
FF 2022 180
Numero
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A060108-03 17.12.2021
BL
Till Voss Swiss Tropical and Public Health Institute Kreuzstrasse 2 4123 Allschwil
An integrative approach to understand antigenic variation in the malaria parasite Plasmodium falciparum
A060128-03 13.09.2021
BE, FR
Dobrila Dimitrijevic MCL Medizinische Laboratorien Freiburgstrasse 634 3172 Niederwangen
Mikrobiologische Diagnostik MCL Labor Niederwangen
A060679-02 07.10.2021
BS
Tobias Schmelzle Novartis Pharma AG Postfach 4002 Basel
Validation of oncology targets by use of shRNAs delivered by lentiviral vectors
A060686-03 21.10.2021
ZH
Steven A. Brown Universität Zürich | Institut für Pharmakologie und Toxikologie Winterthurerstrasse 8057 Zürich
Use of Non-replicating and Self-Inactivating Animal Viruses to Study Signaling Pathways in Cultured Cells.
A070023-03 17.12.2021
VD
John McKinney EPFL - SV Faculté des sciences de la vie Station 19 1015 Lausanne
Persistence mechanisms in Mycobacterium tuberculosis
A090024-03 28.10.2021
BS, BL
Keiser, Jennifer Swiss Tropical and Public Health Institute Socinstrasse 4002 Basel
Helminthen Forschung
A100290-02 17.09.2021
BS
Christoph Dehio Universität Basel, Biozentrum / Pharmazentrum Socinstrasse 4002 Basel
Pathogenesis of Brucella spp.
A110107-02 20.09.2021
TI
Francesco Bertoni Institute of Oncology Research (IOR) Via Vela 5; Via Pometta 1; Via Murate 5A 6500 Bellinzona
Discovery and functional characterization of novel genes involved in the pathogenesis of B and T cell Lymphoma
A110638-02 22.12.2021
BS
Axel Vicart Novartis Pharma AG Postfach 4002 Basel
Isolation, differentiation of immune cells and subsequent stimulation to perform assays, like proliferation or cytokine production
2 / 22
Data d'arrivo
FF 2022 180
Numero
Data d'arrivo
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A120696-05 23.12.2021
ZH
Peter Deplazes Universität Zürich | Institut für Parasitologie Winterthurerstrasse 8057 Zürich
Insect vector competence studies
A120845-12 09.11.2021
VD
Ardemis Boghossian EPFL - SB Faculté des sciences de base Station 1015 Lausanne
Recherches en sciences de base
A120851-22 18.10.2021
VD, GE Brian McCabe EPFL - SV Faculté des sciences de la vie Station 19 1015 Lausanne
Recherche en sciences de la vie
A120917-04 09.11.2021
ZH
Joëlle Schläpfer Universität Zürich Institut für Pflanzenbiologie Zollikerstrasse 107 8008 Zürich
Class 1 Activities at Institute of Plant and Microbial Biology, University of Zurich
A120919-03 15.12.2021
NE
William Marshall production de facteur VIII Baxalta Manufacturing Sàrl recombinant Route de Pierre-à-Bot 2000 Neuchatel
A130556-06 01.10.2021
ZH
Jean-Christophe Leroux Globalmeldung der ETH ETHZ, Departement CHAB, Zürich, Gruppe Leroux Institut für Pharmazeutische Wissenschaften, Drug formulation + delivery Vladimir Prelog-Weg 1-5/10 8093 Zürich
A130946-05 01.12.2021
BS
Jörg Schreiber ETHZ, Departement BSSE, Department of Biosystems Science and Engineering | Department of Biosystems Science and Engineering Mattenstrasse 4058 Basel
Generation of viral vectors and packaging cells that use gene products derived from adenovirus and adeno-associated virus
A131218-05 01.10.2021
BS, BL
Simon Ittig Universität Basel, Biozentrum / Pharmazentrum Klingelbergstrasse 4056 Basel
Bacteria as protein delivery tool
3 / 22
FF 2022 180
Numero
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A140521-01 21.09.2021
VD
Genrich Tolstonog CHUV - Centre hospitalier universitaire vaudois Rue du Bugnon 25A Bâtiment Agora centre de recherche oncologique 1011 Lausanne
Generation of geneticallymodified cell lines to study loco-regional recurrence of head and neck cancer in a mouse model
A141388-03 09.12.2021
BS
Francesca Rucci Novartis Pharma AG Postfach 4002 Basel
Handling of human and non human primate primary cells and established cell lines for profiling of new therapeuticals
A141435-02 22.10.2021
GE
Luc Stoppini Fondation campus Biotech Geneva Chemin des Mines 1202 Genève
Utilisation de cellules et lignées cellulaires de classe 1
A150513-03 21.12.2021
VD
Ashwin Thampi Quotient Suisse SA, Laboratoire de contrôle qualité en microbiologie Route de Crassier 1262 Eysins
Laboratoire de contrôle qualité en microbiologie
A151445-02 14.12.2021
BS
Vincent Trebosc BioVersys AG Hochbergerstrasse 4057 Basel
Erweiterung des Tätigkeitsbereiches um Enterobacteriaceae und Galleria mellonella
A151577-07 14.10.2021
ZH
Gabriela Kania USZ, Rheumaklinik und Institut für physikalische Medizin Wagistrasse 8952 Schlieren
Multiorgan involvement in rheumatic diseases
A151634-01 17.11.2021
FR
Katharina Fromm Université de Fribourg, Département de Chimie Chemin du Musée 1700 Fribourg
Antimicrobial surfaces
A161720-02 13.10.2021
VD
Gilbert Greub CHUV - Centre hospitalier universitaire vaudois Rue du Bugnon 48 1011 Lausanne
Activités de diagnostique pour l'ensemble du CHUV (Microbiologie, Hématologie, Immunologie, Pathologie)
4 / 22
Data d'arrivo
FF 2022 180
Numero
Data d'arrivo
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A161881-02 12.11.2021
FR
Christophe Lamy Neuronal circuits Université de Fribourg | matching metabolism and Faculté des sciences et de behavior médecine | Département d'Oncologie, Microbiologie et Immunologie | Chaire de Microbiologie Chemin du Musée 18 PER17 1700 Fribourg
A171932-02 27.09.2021
VD
Johanna Joyce Regulation of Cancer University of Lausanne | progression by innate Department of Fundamental immune cells Oncology | Ludwig Center for Cancer Research Rue du Bugnon 25A 1011 Lausanne
A172013-03 17.09.2021
ZH
Thomas Böddeker Global Notification Class I ETHZ, Departement MATL, Soft and Living Materials, Gruppe Dufresne Vladimir-Prelog-Weg 8093 Zürich
A172027-02 23.12.2021
BS
Tina Rubic Novartis Pharma AG Postfach 4002 Basel
A172056-02 13.10.2021
VD
Pedro Romero Development of strategies University of Lausanne | for cancer immunotherapy Department of Fundamental Oncology | Ludwig Center for Cancer Research Ch. des Boveresses 1066 Epalinges
A182252-02 16.12.2021
ZH
Annatina Romagna KlusLab Witikonerstrasse 15 8032 Zürich
Gesuch um Bewilligung für mikrobiologische Qualitätskontrolle und Umgebungsmonitoring
A182279-02 10.11.2021
BS
Médéric Diard Universität Basel, Biozentrum / Pharmazentrum Spitalstrasse 41 4056 Basel
Regulation of virulence and evolution dynamics of enterobacteriaceae
A192493-01 09.11.2021
BS
Urs Jenal Universität Basel, Biozentrum / Pharmazentrum Spitalstrasse 41 4056 Basel
Infektion biology of Salmonella enterica, Pseudomonas aeruginosa and Staphylococcus aureus
Generation of mousespecific CAR19 T cells and injection into female mice
5 / 22
FF 2022 180
Numero
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A192576-02 24.09.2021
BS
Sravanth Hindupur Novartis Pharma AG Postfach 4002 Basel
Use of viral vectors for target validation
A192750-01 15.11.2021
FR
Csaba Szabo Cyanide-mediated cellular University of Fribourg, metabolic maladaptation Faculty of Science and in Pseudomonas sepsis Medicine | Department of Medicine, Chair of Pharmacology | Building PER 17 Ch. du Musée 1700 Fribourg
A202822-02 06.09.2021
VD
Christoph Merten EPFL - STI Faculté Sciences et Techniques de l'Ingénieur Station 12 1015 Lausanne
A202843-02 23.09.2021
BS
Randall Platt Use of vesicular stomatitis ETHZ, Departement BSSE, virus (VSV) for studying Department of Biosystems virus-host interactions Science and Engineering | Department of Biosystems Science and Engineering Mattenstrasse 4058 Basel
A202859-01 03.09.2021
BS
Pascal Chalus Lonza AG, DPS Hochbergerstrasse 4057 Basel
Physikalische Partikelanalyse von GMMO basierenden Arzneimittel Dareichungsformen
A202952-03 10.12.2021
VD
Priscilla Turelli EPFL - SV Faculté des sciences de la vie Station 19 1015 Lausanne
Improvement of tools to detect specific neutralizing antibodies against SARSCoV-2 and study of the virus replication and virushost cell interactions.
A203032-02 23.12.2021
ZH
Urs Greber Universität Zürich Department of Molecular Life Sciences Schmelzbergstrasse 12 8091 Zürich
Validation screen of clinical compounds against SARS-CoV-2 with high repurposing potential against COVID-19
A203081-01 13.10.2021
ZH
Klaus Eyer Functional single-cell ETHZ, Departement CHAB, analysis Institut für Pharmazeutische Wissenschaften, FIBA, Gruppe Eyer Vladimir-Prelog-Weg 8093 Zürich
6 / 22
Data d'arrivo
Droplet-based microfluidics screening for drug discovery and functional antibodies
FF 2022 180
Numero
Data d'arrivo
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A203094-01 29.09.2021
VD
Manuele Rebsamen UNIL - Département de Biochimie (DB) Chemin des Boveresses 1066 Epalinges
Caractérisation des voies de signalisation du système immunitaire inné
A203115-01 06.09.2021
BE
Yvonne Döring Human neutrophil isolaUniversität Bern, Department tion from healthy volunfor BioMedical Research teer's blood to study the (DBMR) role of neutrophils in Murtenstrasse 31 atherosclerosis 3008 Bern
A203143-02 11.11.2021
BE
Stephen Leib Universität Bern, Institut für Infektionskrankheiten | Institut für Infektionskrankheiten Friedbühlstrasse 3010 Bern
Infection of zebrafish larvae with human coronavirus NL-63 (hCOV NL-63)
A203148-01 10.11.2021
BS
Médéric Diard Universität Basel, Biozentrum / Pharmazentrum Spitalstrasse 41 4056 Basel
Interrogating the diversity of gut colonization strategies in multidrug-resistant E. coli to deduce robust competitive exclusionbased treatments
A203159-01 21.10.2021
ZH
Melissa Vrohlings CDR-Life AG Wagistrasse 27 8952 Schlieren
In vitro pharmacology experiments assessing potency and safety of multispecific antibodies for tumor-targeted immunotherapies
A210030-02 16.12.2021
ZH
Adriano Aguzzi USZ, Institut für Neuropathologie Schmelzbergstrasse 8091 Zürich
SARS-CoV2 Diagnostics
A210062-01 24.12.2021
FR
Barbara Rothen-Rutishauser Globalmeldung Université de Fribourg, Adolphe Merkle Institut Ch. de Verdiers 1700 Fribourg
A210105-01 08.10.2021
BE
Heike Schmidt-Posthaus Universität Bern, Zentrum für Fisch- und Wildtiermedizin (FIWI) Department of Infectious diseases and pathobiology (DIP) Länggassstrasse 122 3001 Bern
Optimisation of diagnosis of the reportable crayfish plague (Aphanomyces astaci) by genotyping
7 / 22
FF 2022 180
Numero
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210126-01 26.10.2021
ZH
Shana J Sturla ETHZ, Departement HEST, Labor für Lebensmittelund Ernährungstoxikologie (Sturla) Schmelzbergstr. 9 8092 Zürich
Studies on the influence of food compounds and environmenal chemicals on enzymes involved in drug metabolism and DNA alkylation
A210131-01 01.12.2021
FR
Fabio Zobi Université de Fribourg, Département de Chimie Chemin du Musée 1700 Fribourg
Cancer cell culture lab
A210144-01 12.11.2021
ZH
Tristan Heintz Analytics with commerRejuveron Life Sciences AG cially available mammaWagistrasse 18 lian RG1-GMO cell lines 8952 Schlieren
A210152-01 29.11.2021
TI
Santiago Fernandez Gonzalez Institute for Research in Biomedicine via Francesco Chiesa 5 6500 Bellinzona
A210203-02 22.11.2021
TG, ZH
Thomas Krech Prof. MD DiAMiSANTO GmbH Murgstrasse 2, Korrespondenzadresse: Rheinstrasse 1 8500 Frauenfeld
A210211-01 28.12.2021
VD
christelle vogne ANAMED 88 RUE DE GENEVE 1014 LAUSANNE
A210246-00 01.09.2021
ZH
Nina Stanczyk Volatile odours of ETHZ, Departement USYS, mosquito larvae Institut für Agrarwissenschaften, Biokommunikation / Entomologie Schmelzbergstrasse 9 8092 Zürich
A210247-01 14.09.2021
BL
Catherine Vaillant Idorsia Pharmaceuticals Ltd.
Hegenheimermattweg 91 4123 Allschwil
8 / 22
Data d'arrivo
Immune responses to respiratory pathogens
Laboratoire de microbiologie
Development of small molecules modifiers of alpha-synuclein aggregation and neurotoxic properties in in vitro cellular and biochemistry assays
FF 2022 180
Numero
Data d'arrivo
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210248-00 01.09.2021
ZH
Rolf Kümmerli Cooperation, competition University of Zurich, and virulence of PseudoDepartment of Quantitative monas aeruginosa Biomedicine (DQBM) Winterthurerstrasse190 8057 Zurich
A210249-00 01.09.2021
ZH
Rolf Kümmerli University of Zurich, Department of Quantitative Biomedicine (DQBM) Winterthurerstrasse190 8057 Zurich
Virulence and interaction networks between bacterial opportunistic human pathogens
A210250-00 02.09.2021
VD
Brian McCabe EPFL - SV Faculté des sciences de la vie Station 19 1015 Lausanne
Investigating the role of the NF-kB pathway in ALS pathology
A210251-00 03.09.2021
ZH
Mustafa Khammash Talking to Living Cells ETHZ, Departement BSSE, Department of Biosystems Science and Engineering | Department of Biosystems Science and Engineering Rämistrasse 71 / 101 8006 Zürich
A210252-02 24.09.2021
BE
Yvonne Döring Human B cells and Universität Bern, Department monocytes isolation from for BioMedical Research healthy volunteer's blood (DBMR) to study the role of cell Murtenstrasse 31 specific deletion of the 3008 Bern atypical chemokine receptor 3 (ACKR3) in atherosclerosis
A210253-00 06.09.2021
BS
Margherita Turco Friedrich Miescher Institute or Biomedical Research Maulbeerstrasse 66 4058 Basel
Investigating human placental development and its interactions with the maternal uterine microenvironment
A210254-00 06.09.2021
TI, BE
Nicola Schoenenberger Stiftung INNOVABRIDGE Contrada al Lago 6987 Caslano
Learning event on GMOs - detection of CP4-EPSPS in plant tissue with Lateral Flow Immunoassays
A210255-00 07.09.2021
ZH
Helena Villuendas García Hyperthermia of cancer ETHZ, Departement MAVT, cells level 1 Nanophotonics Systems Lab, Gruppe Quidant Tannenstrasse 3, CLA 8092 Zurich
9 / 22
FF 2022 180
Numero
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210256-00 07.09.2021
VD
Rajwinder Lehal Cellestia Biotech Route de la Corniche 6 1066 EPALINGES
Drug discovery program
A210257-00 07.09.2021
BS, ZH
Ben Roediger Novartis Pharma AG Postfach 4002 Basel
Investigating molecular drivers of regulatory T cells suppressive function
A210258-00 08.09.2021
ZH
Lars Fieseler ZHAW, Life Sciences und Facility Management Einsiedlerstrasse 29 & 31 8820 Wädenswil
Isolierung und Charakterisierung von Bakteriophagen
A210259-00 09.09.2021
VD
Aurélie Jayol-Virely eHnv Entremonts 1400 Yverdon
Activités du laboratoire de microbiologie des eHnv
A210260-00 09.09.2021
ZH
Lars Fieseler ZHAW, Life Sciences und Facility Management Einsiedlerstrasse 29 & 31 8820 Wädenswil
Nachweis und Verhalten pathogener Bakterien in Lebensmitteln
A210261-00 09.09.2021
BS
Jen Champoux Analytical assessment of Monte Rosa Therapeutics AGprimary fibroblasts from Klybeckstrasse 191 - WKL rare genetic disease 136.3 4057 Basel
A210262-00 09.09.2021
ZH
Nicola Aceto Molecular Oncology ETHZ, Departement BIOL, Institute of Molecular Health Science Otto-Stern-Weg 8093 Zürich
A210263-00 13.09.2021
BL
Dominik Meinel microbiome DNA Fachhochschule Nordwest- extraction schweiz | Hochschule für Life Sciences Hofackerstrasse 4132 Muttenz
A210264-00 14.09.2021
VD
Sylvia Rothenberger Aubert Development of novel CHUV - Centre hospitalier antiviral therapeutics universitaire vaudois against RSV Rue du Bugnon 48 1011 Lausanne
10 / 22
Data d'arrivo
FF 2022 180
Numero
Data d'arrivo
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210265-00 14.09.2021
BL
Michael Erb SGS Analytics Switzerland AG Sternenfeldstrasse 14 4127 Birsfelden
Qualitätskontrolle viraler Impfstoff
A210266-00 15.09.2021
VD
Nicolas Toni CHUV - Centre hospitalier universitaire vaudois Rte de Cery CNP 1008 Prilly
Etude de la neurogénèse adulte
A210267-00 15.09.2021
BS
Birke Mebold Universitätsspital Basel | Mikrobiologielabor | Labormedizin Petersgraben 4031 Basel
Diagnostic detection of genetic modified Yersinia
A210268-00 15.09.2021
ZH
Didier Surdez Bone Sarcoma Research Laboratory Lengghalde 5 8008 Zurich
modification de lingées cellulaires de cancer pédiatriques par approche CRISPR
A210269-00 17.09.2021
BS
Alex Odermatt Universität Basel, Biozentrum / Pharmazentrum Klingelbergstrasse 50 4056 Basel
New insights in steroid and xenobiotic metabolism, hormone receptor activation and the proteome of the endoplasmic reticulum
A210270-01 21.12.2021
BS
Christoph Dehio Universität Basel, Biozentrum / Pharmazentrum Spitalstrasse 41 4056 Basel
Pathogenesis of Brucella spp.
A210271-00 20.09.2021
ZH
Tobias Wermelinger ZHAW, Life Sciences und Facility Management Einsiedlerstrasse 29 & 31 8820 Wädenswil
Einbau von Reportergenen in feline Caliciviren zum Einsatz in antiviralen Testverfahren
A210272-01 03.12.2021
GE
Serge Rudaz Université de Genève, CMU (Centre Médical Universitaire) 1 Rue Michel Servet 1211 Genève
Targeted and untargeted metabolomic phenotyping of diverse biological samples
A210273-00 21.09.2021
ZH
Celine Maeder Cellular models for lung Rejuveron Life Sciences AG regeneration Wagistrasse 18 8952 Schlieren
11 / 22
FF 2022 180
Numero
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210274-00 22.09.2021
AG
Heike Keilhack Hirslanden Klinik Aarau | Institut für Labormedizin Schänisweg 5001 Aarau
PCR-Analytik von spitalhygienisch relevanten Organismen auf dem GeneXpert (SARS-CoV-2, Influenza A/B, RSV, C.
difficile, Norovirus)
A210276-00 24.09.2021
BE
Charaf Benarafa Institut für Virologie und Immunologie Sensemattstr.
3147 Mittelhäusern
In vivo studies with highly pathogenic coronaviruses
A210277-00 27.09.2021
GE
Patrycja Nowak-Sliwinska CMU_global class 1 Université de Genève, CMU notification (Centre Médical Universitaire) 1 Rue Michel Servet 1211 Genève
A210278-00 27.09.2021
ZH
Simon Breitler EraCal Therapeutics Wagistrasse 13 8952 Schlieren
A210279-00 28.09.2021
ZH
Helena Villuendas García Hyperthermia of nonETHZ, Departement MAVT, cancer cells level 2 Nanophotonics Systems Lab, Gruppe Quidant Tannenstrasse 3, CLA 8092 Zurich
A210280-00 28.09.2021
ZH
Alexander Mathys ETHZ, Departement HEST, IFNH, Sustainable Food Processing, Gruppe Mathys Schmelzbergstrasse 8092 Zürich
Microalgae, fungi and bacteria research for sustainable food processing
A210281-00 28.09.2021
GE
Isabella Eckerle Hôpitaux Universitaires de Genève (HUG) Gabriel-perret-Gentil 1211 Genève
Pathogenesis of SARSCoV-2 in single versus dual infections in airway epithelia
A210282-00 29.09.2021
GE
Isabella Eckerle Université de Genève, CMU (Centre Médical Universitaire) 1 Rue Michel Servet 1211 Genève
Pathogenesis of respiratory viruses in the context of co-infection using differentiated airway epithelia
12 / 22
Data d'arrivo
Era-107
FF 2022 180
Numero
Data d'arrivo
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210283-00 01.10.2021
GE
Denis Jabaudon Université de Genève, CMU (Centre Médical Universitaire) 1 Rue Michel Servet 1211 Genève
differentiation of unmodified and genetically modified human embryonic stem (hES) or human induced pluripotent stem (hIPS) cells into 2D somatic cells or 3D organoids
A210284-00 01.10.2021
GE
Gaby Palmer Biology and function of Université de Genève, CMU IL-38 in human myeloid (Centre Médical cells Universitaire) 1 Rue Michel Servet 1211 Genève
A210285-00 02.10.2021
JU
Tim Haye CABI Rue des Grillons 2800 Delémont
Volatiles of Trogoderma granarium
A210286-00 04.10.2021
VD
Aurélie Jayol-Virely eHnv Entremonts 1400 Yverdon
Diagnostic des organismes de classe 2
A210287-00 04.10.2021
VD
Henri Kornmann Ferring Pharmaceuticals 8, Route de la Corniche, 1066 Epalinges
Ferring Biologics Innovation Center
A210288-00 04.10.2021
BS
Patrick Matthias Identification of new Friedrich Miescher Institute antibacterial pathways in or Biomedical Research macrophages.
Maulbeerstrasse 66 4058 Basel
A210289-00 07.10.2021
BE, AG, Thomas Bodmer ZH Dr. Risch AG, Liebefeld Thunstrasse 46 3110 Münsigen
Ausserbetriebnahme von mobilen COVID Laboratorien (LaborTruck)
A210290-00 07.10.2021
BS
Luigi Talamo Bacthera AG Hochberger Str. 60a 4057 Basel
Abfüllung und Qualitätskontrolle von Live Biotherapeutic Products
A210291-00 07.10.2021
BS
Joana Silva Novartis Pharma AG Postfach 4002 Basel
Loss of function shRNA screens to identify sensitizers to radiation
13 / 22
FF 2022 180
Numero
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210292-00 08.10.2021
TI
Francesco Bertoni Institute of Oncology Research (IOR) Via Chiesa 5 6500 Bellinzona
Development of a microfluidic platform for realtime detection of SARSCoV-2 virus based on multifunctional silica membrane biosensors
A210293-00 08.10.2021
GE
Patrycja Nowak-Sliwinska CMU_global class 1 Université de Genève, CMU notification (Centre Médical Universitaire) rue Michel Servet 1206 Genève
A210294-00 08.10.2021
VD
Caroline Arber Barth CHUV - Centre hospitalier universitaire vaudois Rue du Bugnon 25A Bâtiment Agora centre de recherche oncologique 1011 Lausanne
Development of cell based personalized immunotherapies for hematologic malignancies
A210295-00 14.10.2021
VD
Anne Vassalli UNIL - Département des Sciences Biomédicales Bugnon 1005 Lausanne
Interplay of dopaminergic and orexinergic circuits in shaping vigilance states and motivated behavior
A210296-00 15.10.2021
BL
Marcel Goverde Idorsia Pharmaceuticals Ltd.
Gewerbestrasse 14 4123 Allschwil
Microbiological quality control laboratory for the testing of pharmaceutical samples
A210301-03 22.10.2021
NE
pierre Lemarchand Etilab SA Baconnière 43 2017 Boudry
Activité de diagnostique médical
A210302-00 21.10.2021
ZH
Stephanie Jungmichel CDR-Life AG Wagistrasse 27 8952 Schlieren
Isolation and Analysis of PBMCs from human whole blood of healthy volunteers
A210303-00 21.10.2021
GE
Emi Nagoshi Université de Genève, Sciences III 30, Quai Ernest-Ansermet 1211 Geneva
In virto assessment of the neuroprotective potential of NATO3
A210304-00 25.10.2021
GE
Axel Finckh Université de Genève, CMU (Centre Médical Universitaire) 1 Rue Michel Servet 1211 Genève
Discovering new biomarkers by large «multiomics» analysis to identify individuals in pre-clinical stages of Rheumatoid Arthritis.
14 / 22
Data d'arrivo
FF 2022 180
Numero
Data d'arrivo
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210305-00 26.10.2021
ZH
Francesca Dennert Eidgenössische Forschungsanstalt WSL Zürcherstrasse 8903 Birmensdorf ZH
Infektionsversuche an in Mitteleuropa verbreiteten Baumarten mit X.
fastidiosa
A210306-00 27.10.2021
BE
Ronald Dijkman Universität Bern, Institut für Infektionskrankheiten | Institut für Infektionskrankheiten Friedbühlstrasse 51 3001 BERN
Characterization of human and bovine Respiratory Syncytial Virus host interactions in primary airway epithelium
A210307-00 27.10.2021
VD
Denarda Dangaj CHUV - Centre hospitalier universitaire vaudois Rue du Bugnon 25A Bâtiment Agora centre de recherche oncologique 1011 Lausanne
Systems tumor microenvironment and biomarker discovery
A210308-00 27.10.2021
ZH
Knut Husmann Balgrist Campus, Swiss Center for Musculoskeletal Biobanking (SCMB) Lengghalde, 5 8008 Zurich
Arbeiten und Lagerung von humanem Material unter BSL1 und BSL2 Bedingungen
A210309-00 27.10.2021
VD
Alexandre Harari CHUV - Centre hospitalier universitaire vaudois Rue du Bugnon 25A Bâtiment Agora centre de recherche oncologique 1011 Lausanne
Development of novel strategies for cell-based cancer immunotherapy
A210310-00 28.10.2021
AG
Aude Peyret Solvias AG Römerpark 4303 Kaiseraugst
Bestimmung von BSA, Benzonase und HCP mittels ELISA
A210311-00 28.10.2021
ZH
Ben Hale Universität Zürich, Institut für Medizinische Virologie Winterthurerstrasse 190 8057 Zürich
Paramyxovirus-host interactions
A210312-00 28.10.2021
GE
Caroline Tapparel Vu Université de Genève, CMU (Centre Médical Universitaire) 1 Rue Michel Servet 1211 Genève
Assessing the efficiency of protein and iron-based granular material for the filtration of virus-loaded aerosols
15 / 22
FF 2022 180
Numero
Data d'arrivo
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210313-00 01.11.2021
VD
Laurent Perez Neutralization antibody CHUV - Centre hospitalier against RSV universitaire vaudois Chemin des Boveresses 155 1066 Epalinges
A210315-00 04.11.2021
ZH
Timothy Cash Storage of mammalian Rejuveron Life Sciences AG cells at Rejuveron Life Wagistrasse 18 Sciences 8952 Schlieren
A210316-00 05.11.2021
BL
Simon Ittig Swiss Tropical and Public Health Institute Kreuzstrasse 2 4123 Allschwil
Bacteria as protein delivery tool
A210317-00 06.11.2021
ZH
Thomas Krech DiAMiSANTO GmbH Flughafenstraasse 8302 Kloten
Standortänderung Flughafen Zürich
A210318-00 07.11.2021
FR
Barbara Rothen-Rutishauser Zell-Linien / ReporterzellUniversité de Fribourg, Linien Adolphe Merkle Institut Ch. de Verdiers 1700 Fribourg
A210319-00 09.11.2021
BS
Dominik Brücher Vector Ridgeline Discovery GmbH Hochbergerstrasse 60C, Technologiepark 4057 Basel
A210320-00 09.11.2021
VD
Laurence Winkel EPFL - SV Faculté des sciences de la vie Station 19 1015 Lausanne
Tests of media for microbial cultures
A210321-00 09.11.2021
GE
JORG DIETER SEEBACH Université de Genève, CMU (Centre Médical Universitaire) 1, rue Michel Servet 1206 Geneva
Cell ingeneering using PiggyBac systems, transduction of cell and use of pseudovirus
A210322-00 11.11.2021
VD
Olivier Schumpp Diagnostic ToBRFV Agroscope (Changinsexceptionnel Wädenswil, Nyon, Conthey, Pully, Cadenazzo) Route de Duillier 1260 Nyon 1
16 / 22
FF 2022 180
Numero
Data d'arrivo
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210323-00 11.11.2021
ZH
Nicholas Bokulich microbial ecology of ETHZ, Departement HEST, food fermentations IFNH, Food Systems Biotechnology, Gruppe Bokulich schmelzbergstrasse 7 8006 Zurich
A210324-00 11.11.2021
LU
Max Rosskopf laboRvet AG Wiggermatte 16 6260 Reiden
veterinärmedizinisches Diagnostiklabor
A210325-00 15.11.2021
FR
Stefan Salentinig Stefan Université de Fribourg, Département de Chimie Chemin du Musée 1700 Fribourg
Antimicrobial surfaces
A210326-01 15.11.2021
FR
Katharina Fromm Université de Fribourg, Département de Chimie Chemin du Musée 1700 Fribourg
Production de protéines
A210327-00 15.11.2021
ZH
Robert Katzschmann Biohybrid soft robots ETHZ, Departement MAVT, Gruppe Katzschmann Tannenstrasse 3 8092 Zurich
A210328-00 15.11.2021
BS
Camilo Perez Universität Basel, Biozentrum / Pharmazentrum Spitalstrasse 41 4056 Basel
Cell wall biosynthesis of Gram-positive bacteria
A210329-00 15.11.2021
BS
Attila Becskei Universität Basel, Biozentrum / Pharmazentrum Spitalstrasse 41 4056 Basel
Microbial analysis of oral and skin flora
A210330-00 16.11.2021
BS
Andreas Moor ETHZ, Departement BSSE, Department of Biosystems Science and Engineering | Department of Biosystems Science and Engineering Mattenstrasse 4058 Basel
Use of pseudotyped barcoded RABIES virus to trace cell interactions during cancerogenesis
A210331-00 16.11.2021
ZH
Hans-Anton Keserue rqmicro AG Brandstrasse 24 8952 Schlieren
Methodenentwicklung zur Quantifizierung von Mikroorganismen
17 / 22
FF 2022 180
Numero
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210332-00 16.11.2021
BS
Roy Meoded BrightPeak Therapeutics Klybeckstrase 4057 Basel
Biochemistry lab operations
A210333-00 17.11.2021
SO
Philipp Walter Institut für Labormedizin Solothurner Spitäler AG Schöngrünstrasse 42 4500 Solothurn
Multiplex PCR auf respiratorische Erreger inkl. SARS-CoV-2
A210334-00 18.11.2021
BS
Josef Kapfhammer Departement Biomedizin (DBM), Pestalozzistrasse (Anatomisches Institut), Universität Basel Pestlozzistrasse 4056 Basel
Globalmeldung
A210335-00 19.11.2021
VD
Francesca Amati UNIL - Département des Sciences Biomédicales Bugnon 1005 Lausanne
Organelle contacts in metabolism and aging
A210336-00 19.11.2021
VD
Chao Can EPFL - SV Faculté des sciences de la vie Station 19 1015 Lausanne
Applications of biological nanopores for singlemolecule sensing
A210337-00 19.11.2021
ZH
Florian Renoux Use of VSVG p Repertoire Immune seudotyped retrovirus Medicines (Switzerland) AG Wagistrasse 27 8952 Schlieren
A210338-00 19.11.2021
ZH
Florian Renoux Use of VSVG Repertoire Immune pseudotyped retrovirus Medicines (Switzerland) AG Wagistrasse 27 8952 Schlieren
A210339-00 22.11.2021
ZH
Adrien Foca Molecular Partners AG Wagistrasse 8952 Schlieren
Assessment of antiviral activity for risk group 2 viruses
A210340-00 23.11.2021
BS
Daniela Finke Departement Biomedizin (DBM), Mattenstrasse, Universität Basel Mattenstrasse 4058 Basel
Immunantwort gegen Infektionen in der Maus
18 / 22
Data d'arrivo
FF 2022 180
Numero
Data d'arrivo
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210341-00 23.11.2021
BS
Jean Pieters Universität Basel, Biozentrum / Pharmazentrum Spitalstrasse 41 4056 Basel
Analysis of infections
A210342-00 24.11.2021
ZH
Shinichi Sunagawa Precision Microbiota ETHZ, Departement BIOL, Engineering Institut für Mikrobiologie Vladimir-Prelog-Weg 8093 Zürich
A210343-00 24.11.2021
ZH
Dominik Müller Wotchout GmbH Level 0, Raum A-0-218 8060 Flughafen Zürich
SARS-CoV-2 Diagnostik
A210344-00 25.11.2021
TI, ZH
Federica Sallusto Institute for Research in Biomedicine via Francesco Chiesa 5 6500 Bellinzona
Isolation and characterization of human monoclonal antibodies against infectious agents and self antigens
A210345-00 26.11.2021
AG
Le Yu Solvias AG Römerpark 4303 Kaiseraugst
Identification of the biolological product or preparation of Lentiviral vectors, Flash Therapeutics
A210346-00 28.11.2021
ZH
Dominik Müller Wotchout GmbH Hertistrasse 1 8304 Wallisellen
SARS-CoV-2 Diagnostik
A210347-00 29.11.2021
SH
Karen Neuhold Cilag AG Hochstr.
8205 Schaffhausen
Entwicklung und Anwendung von Qualitätskontrollmethoden für biologische Therapeutika
A210348-00 30.11.2021
VD
Henning Stahlberg EPFL - SB Faculté des sciences de base Bâtiment BSP, Rte de la Sorge 1015 Lausanne
Characterization of protein aggregates in neurodegenerative diseases
A210349-00 01.12.2021
BS
Christoph Dehio Universität Basel, Biozentrum / Pharmazentrum Spitalstrasse 41 4056 Basel
Mutagenese von Bartonella spp. und Klonierung von Bartonella spp. in Bartonella spp.
A210350-00 01.12.2021
FR
Fabio Zobi Université de Fribourg, Département de Chimie Chemin du Musée 1700 Fribourg
Notification globale
19 / 22
FF 2022 180
Numero
Data d'arrivo
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210351-00 02.12.2021
ZH
Robert Katzschmann Tissue engineering for ETHZ, Departement MAVT, Bio-hybrid Robotics using Gruppe Katzschmann iPSCs Tannenstrasse 3 8092 Zurich
A210352-00 02.12.2021
ZH
Robert Katzschmann Bio-Hybrid-Robots based ETHZ, Departement MAVT, on muscle cells Gruppe Katzschmann Tannenstrasse 3 8092 Zurich
A210353-01 02.12.2021
FR
Mona Hassan Abdalla SMF lab Rue Pierre Yerly 10 1762 Givisiez
sars-cov2 dignostique
A210354-00 03.12.2021
BS
Vincent Trebosc (inactive) BioVersys AG Hochbergerstrasse 4057 Basel
Erweiterung des Tätigkeitsbereiches
A210355-00 06.12.2021
BS
Georg Petzold BSL1 Bacterial work Monte Rosa Therapeutics AGGlobal Notification Klybeckstrasse 191 - WKL 136.3 4057 Basel
A210356-00 08.12.2021
ZH
Julien Weber In-vitro viral infection by University of Zurich, lowly pathogenic viruses Department of Quantitative Biomedicine (DQBM) Winterthurerstrasse190 8057 Zurich
A210357-00 09.12.2021
ZH
Stephan Arni USZ, Klinik für Thoraxchirurgie Sternwartstrasse 8091 Zürich
CRISPR cloning
A210358-00 10.12.2021
SG
Michael Ritzler Labordiagnostic St.Gallen West Zürcherstrasse 505 9015 St. Gallen
Human medizinische, mikrobiologische Diagnostik
A210359-00 10.12.2021
ZH
Jessica Stapley Resistance to Cercospora ETHZ, Departement USYS, leaf spot in sugar beet Institut für Pflanzenwissenschaften, Phytopathologie Universitätsstrasse 8092 Zürich
20 / 22
FF 2022 180
Numero
Data d'arrivo
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210360-00 13.12.2021
GE
Olivier Bruttin Biostarks Europe Sàrl Ch. de La Voie-Creuse 16 1202 Genève
Demande Biostarks
A210361-00 15.12.2021
BS
Clémentine Le Magnen Universitätsspital Basel Pathologie / Medizinische Genetik Schönbeinstrasse 4031 Basel
Investigating mechanisms driving prostate and bladder cancer progression
A210362-00 15.12.2021
BL
Sebastien Gagneux Swiss Tropical and Public Health Institute Kreuzstrasse 2 4123 Allschwil
Use of mycobacterial species in contained systems to study their global diversity, virulence, immunogenicity as well as the evolution and ecology of drug resistance
A210363-00 17.12.2021
ZH
Salvador Pané i Vidal Biocompatibility of ETHZ, Departement MAVT, magnetoelectric materials Multiscale Robotics Lab (MSRL), Gruppe Nelson Tannenstrasse 3 8092 Zürich
A210364-00 18.12.2021
BL
Christian Nsanzabana Swiss Tropical and Public Health Institute Kreuzstrasse 2 4123 Allschwil
Malaria Molecular epidemiology laboratory
A210365-00 20.12.2021
FR
Heinz Müller Schärer Université de Fribourg, Département de Biologie Chemin du Musée 1700 Fribourg
Keimungsverhalten von drüsigem Springkraut (Impatiens glandulifera)
A210366-00 21.12.2021
ZH
Jasmin Hiestand Collection and Storage Epidemiology, Biostatistics of Human Milk Samples and Prevention Institute | from Lactating Individuals Department of Public Health |Following Covid-19 Infectious Disease Division Vaccination Hirschengraben 8001 Zürich
A210367-00 21.12.2021
ZH
Anja Frei Aliquoting of Human Epidemiology, Biostatistics Urine Samples for the and Prevention Institute | Efficacy, Safety and Department of Public Health |Toxicology of Electronic Infectious Disease Division Nicotine Delivery Systems Hirschengraben as an aid for smoking ces8001 Zürich sation: The ESTxENDS multicentre randomized controlled trial
21 / 22
FF 2022 180
Numero
Data d'arrivo
Cantone di Richiedente / domicilio Sede legale
Titolo, in breve, del progetto
A210368-00 21.12.2021
ZH
Robert Katzschmann Muscle Bioactuators for ETHZ, Departement MAVT, Bio-hybrid Robotics Gruppe Katzschmann Tannenstrasse 3 8092 Zurich
A210369-00 23.12.2021
TI
Manuela Del Torso SSSMT Locarno alla Morettina 3 6600 Locarno
A210370-00 23.12.2021
VD
Yannick Muller Engineering human CHUV - Centre hospitalier lymphocytes for nonuniversitaire vaudois oncological diseases Chemin des Boveresses 155 1066 Epalinges
SSSMT Locarno
L'ordinanza del 9 maggio 2012 sull'impiego confinato (OIConf; RS 814.912) costituisce la base giuridica per la pubblicazione.
Gli interessati possono consultare gli atti non confidenziali presso l'UFAM, divisione suolo e biotecnologia, Worblentalstrasse 68, 3063 Ittigen (www.umwelt-schweiz.ch).
Previo appuntamento presso il Centro di contatto Biotecnologia della Confederazione, UFAM, al n. telefonico +41 58 463 55 99, n. fax +41 58 463 79 78, contact.biotech@bafu.admin.ch.
27 gennaio 2022
Ufficio federale dell'ambiente: Centro di contatto Biotecnologia della Confederazione
22 / 22